Clinical Trials Directory

Trials / Suspended

SuspendedNCT01228656

Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate

CLINICAL EVALUATION OF EFFECTIVENESS OF ASSOCIATION MOMETASONE FUROATE 0.1% AND SALICYLIC ACID 5% COMPARED WITH 0.1% MOMETASONE FUROATE INSULATED TOPICAL USE OF LABORATORY Glenmark Pharmaceuticals Ltd, IN PATIENTS WITH PSORIASIS IN PLATE

Status
Suspended
Phase
Phase 2
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Azidus Brasil · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aims is to evaluate the efficacy and comparative isolation of the association Mometasone furoate + Salicylic Acid and the substance isolated Mometasone furoate produced by the Laboratory Glenmark Pharmaceuticals Ltd. in patients of both sexes, patients with plaque psoriasis grade mild to moderate.

Detailed description

The specific objective is to evaluate through analytical propedeutics medical improvement in clinical signs and symptoms related to plaque psoriasis. The study will be conducted with 40 patients who will deal with two symmetrical lesions of his body being identified by the clinician that a party should be treated in a double-blind only with mometasone furoate cream containing 0.1% and another with the combination of furoate of mometasone 0.1% + Salicylic Acid 5%. The group of patients to be treated must be adults of both sexes, aged 18-70 years with good mental and physical health to sign the Informed Consent and who are clinically assessed by dermatologists in the study as having mild plaque psoriasis and moderate. The association made a proposal of effectiveness was developed and is produced by the Laboratory Glenmark Pharmaceuticals Ltd., as well as its isolated version of the pilot (mometasone furoate 0.1%). This study should be characterized as Phase II multicenter not.

Conditions

Interventions

TypeNameDescription
DRUGmometasone furoate + salicylic acidDermatologic ointment applied once a day.
DRUGMometasone furoateDermatologic ointment applied once a day

Timeline

Start date
2006-09-01
Primary completion
2010-10-01
Completion
2011-10-01
First posted
2010-10-26
Last updated
2022-11-03

Source: ClinicalTrials.gov record NCT01228656. Inclusion in this directory is not an endorsement.